« back to directory

About Sienna Cancer Diagnostics

Sienna Cancer Diagnostics Ltd. is an ASX-listed medical technology company commercialising in-vitro diagnostic tests for the pathology market. Sienna’s first product is an IVD test for the detection of hTERT, a component of telomerase which is found in nearly all epithelial cancers.

The first application of Sienna's hTERT test is as an adjunct to urine cytology to assist in the early diagnosis of bladder cancer.

Sienna is actively working to further penetrate the US market, expand their geographical markets, extend the clinical application of hTERT testing into other cancer areas, and acquire new technologies for their product pipeline.